Bifenthrin

DB15056ExperimentalSmall molecule

Bifenthrin is under investigation in clinical trial NCT01560247 (Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry).

Chemical structure of Bifenthrin
Formula / weight
C23H22ClF3O2 · 422.87 g/mol (avg)
Also known as
CAPTURE

Resolves to

Compound
UNIICNW4AM9VYXCAS82657-04-3ChEMBLCHEMBL2227975ChEBI3093
Clinical / RWD
RxNorm2475177
Structure
InChIKeyOMFRMAHOUUJSGP-IRHGGOMRSA-NSMILESCC1=C(C=CC=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C)C1=CC=CC=C1

What you can answer from here — as of July 14, 2026

1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Bifenthrin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In